It was shown that blocking S1P signaling with an agonist, FTY-720, resulted in increased apoptosis in multiple myeloma cells [46], induced cell death in chronic lymphocytic leukemia [47], and inhibited MCL pathogenesis in a SCID mouse model [40]. This evidence concerns the gene MBTPS1 and plasma cell myeloma.